GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R307. A total of 5 filers reported holding GENETIC TECHNOLOGIES LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $62 | -27.1% | 20 | 0.0% | 0.00% | – |
| Q2 2021 | $85 | +2.4% | 20 | 0.0% | 0.00% | – |
| Q1 2021 | $83 | +15.3% | 20 | 0.0% | 0.00% | – |
| Q4 2020 | $72 | +4.3% | 20 | 0.0% | 0.00% | – |
| Q3 2020 | $69 | +50.0% | 20 | 0.0% | 0.00% | – |
| Q2 2020 | $46 | +17.9% | 20 | 0.0% | 0.00% | – |
| Q1 2020 | $39 | -2.5% | 20 | 0.0% | 0.00% | – |
| Q4 2019 | $40 | +5.3% | 20 | 0.0% | 0.00% | – |
| Q3 2019 | $38 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Scarborough Advisors, LLC | 10,638 | $8,838 | 0.00% |
| Virtu Financial LLC | 18,182 | $15 | 0.00% |
| Gradient Investments LLC | 2,192 | $1,821 | 0.00% |
| NewSquare Capital LLC | 100 | $83 | 0.00% |
| UBS Group AG | 100 | $83 | 0.00% |
| RHUMBLINE ADVISERS | 18,700 | $15,633 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,000 | $831 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 88,356 | $73,406 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 14,906 | $12,384 | 0.00% |